Norges Bank Biocryst Pharmaceuticals Inc Transaction History

Norges Bank

$716 Trillion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $2.69 Million - $4.42 Million	651,635 New	651,635 $4.03 Million
Q4 2023 Feb 09, 2024	BUY	$4.98 - $6.77 $11 Million - $15 Million	2,216,612 New	2,216,612 $13.3 Million
Q3 2023 Nov 13, 2024	BUY	$6.71 - $7.92 $5.68 Million - $6.71 Million	846,612 New	846,612 $5.99 Million
Q3 2023 Nov 13, 2023	SELL	$6.71 - $7.92 $7.2 Million - $8.5 Million	-1,073,116 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$6.96 - $8.81 $1.36 Million - $1.72 Million	194,977 Added 29.92%	846,612 $5.96 Million
Q2 2023 Aug 14, 2023	SELL	$6.96 - $8.81 $13.8 Million - $17.5 Million	-1,985,365 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$7.94 - $11.84 $7.03 Million - $10.5 Million	884,863 New	884,863 $7.38 Million
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $12.1 Million - $16.4 Million	1,152,116 New	1,152,116 $13.2 Million
Q3 2022 Nov 13, 2023	BUY	$10.79 - $14.81 $11.6 Million - $15.9 Million	1,073,116 New	1,073,116 $13.5 Million
Q2 2022 Aug 14, 2023	BUY	$7.89 - $17.88 $15.7 Million - $35.5 Million	1,985,365 New	1,985,365 $21 Million
Q1 2022 May 12, 2023	SELL	$11.56 - $19.76 $4.12 Million - $7.05 Million	-356,588 Reduced 30.95%	795,528 $12.9 Million
Q1 2022 May 09, 2022	SELL	$11.56 - $19.76 $8.3 Million - $14.2 Million	-717,674 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$11.18 - $15.46 $8.02 Million - $11.1 Million	717,674 New	717,674 $9.94 Million
Q3 2021 Nov 14, 2022	BUY	$14.21 - $17.65 $11.3 Million - $14.1 Million	796,674 New	796,674 $11.4 Million
Q3 2021 Nov 05, 2021	SELL	$14.21 - $17.65 $2.43 Million - $3.02 Million	-171,351 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$9.5 - $17.24 $1.63 Million - $2.95 Million	171,351 New	171,351 $2.71 Million
Q2 2021 Aug 10, 2021	SELL	$9.5 - $17.24 $1.63 Million - $2.95 Million	-171,351 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$7.37 - $13.61 $1.26 Million - $2.33 Million	171,351 New	171,351 $1.74 Million
Q1 2021 May 07, 2021	SELL	$7.37 - $13.61 $2.59 Million - $4.77 Million	-350,760 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$3.37 - $8.61 $1.18 Million - $3.02 Million	350,760 New	350,760 $2.61 Million
Q4 2020 Feb 10, 2021	SELL	$3.37 - $8.61 $3.48 Million - $8.89 Million	-1,032,093 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$3.43 - $5.53 $3.54 Million - $5.71 Million	1,032,093 New	1,032,093 $3.55 Million
Q3 2020 Nov 10, 2020	SELL	$3.43 - $5.53 $1.86 Million - $3.01 Million	-543,493 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$1.9 - $5.61 $1.03 Million - $3.05 Million	543,493 New	543,493 $2.59 Million

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$154 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$151 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$89.8 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$68.8 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$67 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account